SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-17-003175
Filing Date
2017-06-15
Accepted
2017-06-15 07:05:28
Documents
5
Period of Report
2017-06-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT s106555_8k.htm 8-K 18215
2 EXHIBIT 99.01 s106555_ex99-01.htm EX-99.01 16167
3 EXHIBIT 99.02 s106555_ex99-02.htm EX-99.02 15056
4 GRAPHIC ex99-01pg1.jpg GRAPHIC 444211
5 GRAPHIC ex99-02pg1.jpg GRAPHIC 11549
  Complete submission text file 0001615774-17-003175.txt   678670
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 17912389
SIC: 2834 Pharmaceutical Preparations